A Multicenter Single-Arm Objective Performance Criteria Trial to Determine the Efficacy and Safety of High-Frequency Irreversible Electroporation as Primary Treatment for Localized Prostate Cancer: A Study Protocol

Biming He(Shanghai East Hospital), Haifeng Wang(Wenzhou University), Shuai-Dong Wang(Shanghai East Hospital), Shancheng Ren(Shanghai Changzheng Hospital), Weigang Yan(Chinese Academy of Medical Sciences & Peking Union Medical College), Wei Xue(National Sun Yat-sen University), Lei Yin(Shanghai Ninth People's Hospital), Linhui Wang(Second Military Medical University), Yi Zhou(Tongji Hospital), Yanqing Wang(Shanghai Jiao Tong University), Xu Gao(Sun Yat-sen University), Zhien Zhou(Chinese Academy of Medical Sciences & Peking Union Medical College), Hai Zhou(Yuncheng University), Zhenkai Shi(Shanghai East Hospital), Baijun Dong(Renji Hospital), Hengzhi Lin(Second Military Medical University), Chuanliang Xu(Second Military Medical University)
Frontiers in Oncology
November 10, 2021
Cited by 6


Related Papers